Account

Industry resources and insights

Sort by year
  • All time
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018 and older
News
13.02.2024
World EPA Congress 2024

The World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...

Read more
Publications
14.03.2024
Advanced Therapies Congress 2024: How could ATMPs ...

Objectives This study delves into the payer perspective of Advanced Therapy Medicinal Products (ATMP...

Read more
Publications
07.03.2024
World EPA Congress 2024: Implications of indicatio...

The study explores the complexities of pricing and reimbursement for multi-indication products in th...

Read more
Insider Insights
07.03.2024
EU releases draft act on Joint Clinical Assessment...

Consultation launched on EU draft Regulation for joint clinical assessments, seeking feedback to imp...

Read more
Articles
05.03.2024
VPAG for manufacturers: boom or gloom for UK launc...

We discuss the 2024 VPAG agreement, how it differs from the previous VPAS and whether this will impa...

Read more
Webinar
28.02.2024
VPAS is dead, long live VPAG: the impact of the UK...

Webinar: Discussions on the new Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (...

Read more
Insider Insights
23.02.2024
New Committee Paves the Way for Biosimilar Substit...

ANSM establishes a Temporary Scientific Committee to promote biosimilar substitution, enhancing pati...

Read more
Load more
Browse by topic
  • Biosimilars
  • Devices & Diagnostics
  • Digital Health
  • Early Access
  • Early Payer Dialogue
  • Emerging & Developing Markets
  • Funding
  • Gene Therapy & ATMPs
  • HTA
  • International Reference Pricing
  • Launch
  • Managed Entry Agreements
  • Medicine manufacturing
  • NICE
  • Oncology
  • Orphan Drugs
  • PMA Trends
  • Pricing
  • Rare Diseases
  • Real World Evidence
  • Team Remap
  • Tendering & Procurement
  • Training
Content type
  • All
  • Articles
  • Case Study
  • Insider Insights
  • News
  • Publications
  • Webinar
Subscribe
Hidden
This field is for validation purposes and should be left unchanged.